The stock of Quantum BioPharma Ltd (QNTM) has seen a -27.46% decrease in the past week, with a 68.60% gain in the past month, and a -8.86% decrease in the past quarter. The volatility ratio for the week is 19.58%, and the volatility levels for the past 30 days are at 24.83% for QNTM. The simple moving average for the past 20 days is -37.03% for QNTM’s stock, with a -34.64% simple moving average for the past 200 days.
Is It Worth Investing in Quantum BioPharma Ltd (NASDAQ: QNTM) Right Now?
The 36-month beta value for QNTM is at 0.30. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for QNTM is 1.59M, and currently, shorts hold a 3.42% of that float. The average trading volume for QNTM on February 28, 2025 was 2.44M shares.
QNTM) stock’s latest price update
The stock of Quantum BioPharma Ltd (NASDAQ: QNTM) has decreased by -14.38 when compared to last closing price of 5.77. Despite this, the company has experienced a -27.46% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-11 that TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced it has retained the services of MZHCI, LLC, an MZ Group Company (“MZ”), to lead a comprehensive strategic investor relations and financial communications program across all key markets.
QNTM Trading at -6.18% from the 50-Day Moving Average
After a stumble in the market that brought QNTM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.62% of loss for the given period.
Volatility was left at 24.83%, however, over the last 30 days, the volatility rate increased by 19.58%, as shares surge +68.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +17.34% upper at present.
During the last 5 trading sessions, QNTM fell by -27.46%, which changed the moving average for the period of 200-days by -78.36% in comparison to the 20-day moving average, which settled at $7.84. In addition, Quantum BioPharma Ltd saw 34.24% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for QNTM
Equity return is now at value -67.43, with -55.28 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.76.
Conclusion
In conclusion, Quantum BioPharma Ltd (QNTM) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
